Publication Beamlines Strategic Pillar
(2021). Sixty‐Seventh Annual Scientific Meeting of Canadian Organization of Medical Physicists. Medical Physics 48(8) , 4666-4666. 10.1002/mp.15102. BMIT-ID Materials
(2020). Scientific Abstracts and Sessions. Medical Physics 47(6) , E702-E702. 10.1002/mp.14316. BMIT-ID Materials
(2010). Goldschmidt Abstracts 2010 – B. Geochimica et Cosmochimica Acta 74(12) , A38-A134. 10.1016/j.gca.2010.04.027. SM
(2024). Exit Window for Electron Beam in Isotope Production. Patent Number: IL268283B2.
(2019). Prolactin receptor binding proteins and uses thereof. Patent Number: IL239502B.
(2018). . Patent Number: NO2968312T3.
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2018). Antibody polypeptides that antagonize cd40. Patent Number: IL228720B.
(2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T.
(2018). Methods and compositions. Patent Number: GB201817444D0.
(2018). . Patent Number: NO2699601T3.
(2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A.
(2018). Antibody epitope. Patent Number: IL256097A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.